Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

NCT04990479 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by Sponsor

Conditions

Melanoma (Skin)
Non-Small-Cell Lung Carcinoma

Interventions

BIOLOGICAL: GAd-PEV
BIOLOGICAL: MVA-PEV

Sponsor

Nouscom SRL